Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad26.COV2.S Heterologous Booster Following Inactivated COVID-19 Vaccine
NCT05109559Phase 2Unknown
- Sponsor
- Mahidol University
- Start
- Dec 2021
- Primary completion
- Dec 2023
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Ad26.COV2.S in coronavirus disease 2019 (COVID-19), sponsored by Mahidol University. Status: unknown.
02
Drugs
Ad26.COV2.S
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05109559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05109559.